Global regulatory agility during covid-19 and other health emergencies

An Omani infant boy who presented in the neonatal period with cardiac failure secondary to hypertrophic cardiomyopathy is reported. He subsequently progressed to show features of a metabolic disorder with multisystem involvement and was diagnosed to have Type II glycogenosis (Pompe9s disease). The differential diagnosis and management of metabolic cardiomyopathy are outlined.